Iph Ltd. · ASX:IPH
Iph — Investor Presentation (February 2025)
35 slides from Iph's investor presentation, Feb 20, 2025
Slide 1: 2025 Half Year Results Investor Presentation
iphltd.com.au 2025 Half Year Results Investor Presentation Half year ended 31 December 2024 20 February 2025 Presented by: Dr. Andrew Blattman Managing Director & CEO, IPH Limited John Wadley Chief Financial Officer, IPH Limited
Slide 2: Disclaimer
2025 Half Year Results Investor Presentation iphltd.com.au 2 Disclaimer This document has been prepared by IPH Limited (IPH) and comprises written materials/slides for a presentation concerning IPH. This presentation is for information purposes only and does not constitute or form part of any offer
Slide 3: Contents
2025 Half Year Results Investor Presentation iphltd.com.au 3 01 HY25 highlights 6 02 HY25 results 9 Contents 03 04 Regions update Summary and priorities 17 22 05 Appendix 26
Slide 4: About the IPH Group
iphltd.com.au 4 About the IPH Group A leading international IP services group IPH coverage Primary IP markets Patent group Trade mark group No.1 in Australia, Canada, New Zealand and Singapore 1 in Australia, Canada and New Zealand1 IPH offices Secondary IP markets 26 IP jurisdictions 1,800+ Employe
Slide 5: Vision, Purpose, Aspirations
2025 Half Year Results Investor Presentation iphltd.com.au 5 Vision Aspirations The partner of choice enabling global IP protection Clients for the world’s innovators. Providing the world’s innovators with exceptional quality, responsive service and great value Position Purpose Number 1 and growing
Slide 6: HY25 highlights
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 6 HY25 highlights
Slide 7: Solid financial result in challenging market
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 7 Solid financial result in challenging market Continued organic growth in ANZ; strong recovery in IPH Asian patent filings in 2Q Continued organic growth in ANZ Like
Slide 8: Progress in HY25
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 8 Progress in HY25 In HY25 Organic growth in ANZ despite filing headwind Promising growth in Asian filings (ex Singapore) in last quarter of calendar 2024 CIPO process
Slide 9: HY25 results
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 9 HY25 results
Slide 10: Financial overview
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 10 Financial overview Underlying revenue and earnings growth with strong cash conversion 25% 6% Revenue1 Interim Dividend 2 $344.3m 17 cents per share 27% 11% EBITDA
Slide 11: Like for like earnings
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 11 Like for like earnings Continued organic growth in ANZ; recovery in Asia; Canada earnings impacted by CIPO issues ANZ Asia Canada Group Revenue1 4% 0% 8%** 4% Unde
Slide 12: Underlying Results
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 12 Underlying Results Adjustments relate primarily to Bereskin & Parr acquisition HY25 HY25 Statutory EBITDA 95.0 Adjustments Statutory Underlying 3 Business acquisit
Slide 13: Cash flow statement
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 13 Cash flow statement $'m 31 Dec 2024 31 Dec 2023 Continued strong cash generation – Statutory EBITDA 95.0 74.8 cash conversion ratio 100% Non-operating adjustments
Slide 14: Balance sheet
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 14 Balance sheet Strong financial position maintained with net debt reduced by 16% $'m 31 Dec 2024 30 Jun 2024 As a result of the acquisition of Bereskin & Parr and s
Slide 15: Progress on Capital Management
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 15 Progress on Capital Management Strong balance sheet and continued focus on shareholder returns IPH's capital allocation framework Key Achievements Net debt down $5
Slide 16: Foreign currency sensitivity
2025 Half Year Results Investor Presentation HY25 highlights HY25 r esults Regions update Summary & priorities Appendix iphltd.com.au 16 Foreign currency sensitivity Earnings currency Balance sheet HY25 HY25 sensitivity sensitivity Operating Expenses Service Charges • Based on the USD profile in HY2
Slide 17: Regions update
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 17 Regions update
Slide 18: Australia/New Zealand
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 18 Australia/New Zealand Organic growth despite lower market patent filings Financial Metrics 1H25 1H24 % Change Like-for-like Market commentary: Revenue 158.5 148.6 7
Slide 19: Asia
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 19 Asia Ongoing recovery with IPH patent filings up 10% in first half Financial Metrics 1H25 1H24 % Change Like-for-like Market commentary: Revenue 60.5 60.3 0% 0% > I
Slide 20: Canada
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 20 Canada Solid performance despite challenges, with integration milestones surpassed Financial Metrics 1H25 1H24 % Change Like-for-like Market commentary: Revenue 134
Slide 21: Leveraging market-leading presence in Canada
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 21 Leveraging market-leading presence in Canada Bereskin & Parr synergies above target and growth in client referrals Status update on Bereskin & Parr: Cumulative Refe
Slide 22: Summary and priorities
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Market update Summ ary & priorities Appendix iphltd.com.au 22 Summary and priorities
Slide 23: Priorities for FY25
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Market update Summ ary & priorities Appendix iphltd.com.au 23 Priorities for FY25 Continued focus on shareholder returns Continued focus on organic growth in ANZ and returning to growth in Asia, with strategies including tailo
Slide 24: The partner of choice enabling global IP protection
2025 Half Year Results Investor Presentation iphltd.com.au 24 The partner of choice enabling global IP protection for the world’s innovators. Q&A
Slide 25: Thank you
2025 Half Year Results Investor Presentation iphltd.com.au 25 Thank you The partner of choice enabling global IP protection for the world’s innovators.
Slide 26: Appendix
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 26 Appendix
Slide 27: Like-for-Like earnings
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 27 Like-for-Like earnings Underlying Revenue New Accounting Currency Adjusted Revenue Underlying Revenue Change % Dec 2024 YTD Businesses2 FX Movements3 Adjustment Dec
Slide 28: Underlying results
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 28 Underlying results HY25 Statutory Underlying Adjustments Income Statement Earnings HY253 Total revenue 1 344.3 344.3 Recoverable expenses (89.7) (89.7) Compensation
Slide 29: Supplementary information
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 29 Supplementary information Items below EBITDA The table below details components included in Profit before Tax not included in EBITDA. HY25 assumptions1 are estimate
Slide 30: Patent market – Australia
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 30 Patent market – Australia Organic growth despite lower market patent filings 45,000 40.0% Australian patent filings IPH Group market share2 40,000 – market1 > IPH f
Slide 31: Patent market – Singapore
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 31 Patent market – Singapore IPH tracks broadly in line with market 16,000 30.0% Singapore patent IPH Group market share2 filings – market1 > IPH maintains number one
Slide 32: IPH patent filings – Asia
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 32 IPH patent filings – Asia1 IPH patent filings up across Asia, with acceleration in 2Q 700 > IPH patent filings in Asia (outside of Singapore) increased by 15.1% in
Slide 33: PCT applications filed from US applicants
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 33 US PCT applications CAGR 10 Yr (CY14 to CY23) = -0.8% PCT applications from PCT applications from the US – the US by calendar year1 % change on PY (last 6 months)2
Slide 34: PCT filings
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 34 PCT filings Primary market reflection of steady long-term filing patterns CAGR 10 Yr (CY14 to CY23) = 10.5% CAGR 10 Yr (CY14 to CY23) = 1.5% China PCT Applications
Slide 35: Patent lifecycle
2025 Half Year Results Investor Presentation HY25 highlights HY25 results Regions update Summary & priorities Appendix iphltd.com.au 35 Patent lifecycle Long-life cycle supports consistent revenues and earnings Each year more than half+ of the total patent applications filed in Australia come throug